Unlocking Potential Cures with CRISPR: Indication Selection And Portfolio Strategy For CRISPR-Based Gene Editing Companies

Oct 06, 2021

Posted by Health Advances LLC

The work anywhere paradox

Sep 15, 2021

“Why Don’t Stem-gene Cell Clinical Trial Sponsors Count Their Stem Cells?”

Aug 25, 2021

The search for a better charge model

Aug 04, 2021

Posted by Cresset

Flare™ FEP: Competitively combining speed and accuracy with ease of use

Jul 27, 2021

Posted by Cresset

Regulatory Oversight in Gene Therapy: How Far Have We Come?

Jul 23, 2021

Posted by G&L Healthcare Advisors

Cresset: Your partner for virtual screening whether outsourced and/or in-house

Jul 05, 2021

Posted by Cresset

Managing your CRO partnerships: How to share information effectively and securely

Jul 01, 2021

Posted by Cresset